QINGDAO PORT (06198) reported a net profit attributable to shareholders of RMB4.149 billion for the first three quarters, down 0.76% year on year.
QINGDAO PORT (06198) announced its results for the first three quarters of 2026. The Group recorded operating revenue of RMB15.474 billion, up 8.68% year on year; net profit attributable to shareholders of the listed company was RMB4.149 billion, down 0.76% year on year; basic earnings per share were RMB0.64.
QINGDAO PORT (06198) announced its results for the first three quarters of 2026. The Group recorded operating revenue of RMB15.474 billion, up 8.68% year on year; net profit attributable to shareholders of the listed company was RMB4.149 billion, down 0.76% year on year; basic earnings per share were RMB0.64.
Related Articles
Jiangsu Hengrui Pharmaceuticals (01276): Marketing authorization application for trastuzumab rezetecan for injection accepted and included in priority review process
Hua Hong Grace Semiconductor (01347): Chairman and President proposes share repurchase of the company's A-shares
CHINARES PHARMA (03320): China Resources Boya Bio-pharmaceutical Group's net profit for the first three quarters was RMB60.5883 million, a year-on-year decrease of 82.34%
Jiangsu Hengrui Pharmaceuticals (01276): Marketing authorization application for trastuzumab rezetecan for injection accepted and included in priority review process
Hua Hong Grace Semiconductor (01347): Chairman and President proposes share repurchase of the company's A-shares
CHINARES PHARMA (03320): China Resources Boya Bio-pharmaceutical Group's net profit for the first three quarters was RMB60.5883 million, a year-on-year decrease of 82.34%
